IntriCon to Unveil New Cardiac Diagnostic Monitoring Device at 2009 American Heart Association Scientific Sessions.

ST. PAUL, Minn. -- IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, announced today that it will unveil a prototype of its new Cardiac Diagnostic Monitoring (CDM) device, called the Mobile Patient ECG Telemetry System, or MPETS, at the 2009 American Heart Association (AHA) Scientific Sessions, Nov. 15-17, in Orlando, Fla.

At booth 1663 in the Orange County Convention Center, IntriCon/Datrix will introduce the MPETS, a next-generation wireless outpatient monitoring tool, which uses a proven automatic arrhythmia detection algorithm.

"This is an exciting time for IntriCon--and great news for cardiac diagnostic OEMs and their patients," said Mark S. Gorder, president and chief executive officer at IntriCon. "We have leveraged Datrix's cardiac monitoring capabilities and IntriCon's marketing abilities to develop a new wireless cardiac monitoring device that allows for more patient comfort and the ability to identify asymptomatic cardiac events including atrial fibrillation, Brady arrhythmia, tachy arrhythmia and cardiac pause."

In August 2009, IntriCon acquired Datrix, an Escondido, Calif.-based supplier of CDM devices, to leading medical OEMs. IntriCon's capabilities combined with Datrix's, creates a platform for IntriCon to expand into other physiological monitoring markets. And adding the wireless outpatient telemetry capability gives the company access to the emerging biotelemetry space.

The AHA's Scientific Sessions is the premier cardiovascular meeting that includes programming in three broad areas of clinical, basic and population science as well as cross-disciplinary translational science.

About IntriCon Corporation Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature and micro-miniature body-worn medical and electronics products. The company is focused on three key markets: medical, hearing health, and professional audio and communications. IntriCon has facilities in the United States, Asia and Europe. The company's common stock trades under the symbol "IIN" on the NASDAQ Stock Market. For more information about IntriCon, visit www.intricon.com.

Forward-Looking Statements Statements made in this release and in IntriCon's other public filings and releases that are not historical facts or that include forward-looking terminology such as "may", "will", "believe", "expect", "should", "optimistic" or "continue" or the negative thereof or other variations thereon are "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, without limitation, statements concerning prospects in the miniature body-worn device arena, new products, strategic alliances, future growth and expansion, market fundamentals, future financial condition and performance, prospects and the positioning of IntriCon to compete in chosen markets and the Company's planned investments in research and development. These forward-looking statements may be affected by known and unknown risks, uncertainties and other factors that are beyond IntriCon's control, and may cause IntriCon's actual results, performance or achievements to differ materially from the results, performance and achievements expressed or implied in the forward-looking statements. These risks, uncertainties and factors include, without limitation, risks related to the current economic crisis, the risk that IntriCon may not be able to achieve its long-term strategy, weakening demand for products of the company due to general economic conditions, risks related to the company's strategic alliances and joint venture, possible non-performance of developing the MPETS product and other technological products, the volume and timing of orders received by the company, changes in the mix of products sold, competitive pricing pressures, the cost and availability of electronic components and commodities for the company's products, ability to create and market products in a timely manner, competition by competitors with more resources than the company, foreign currency risks arising from the company's foreign operations, ability to satisfy and maintain compliance with the covenants under the company's loan facility, the costs and risks associated with research and development investments and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2008. The company disclaims any intent or obligation to publicly update or revise any forward-looking statements, regardless of whether new information becomes available, future developments occur or otherwise.